Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Lang

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Clinical Pharmacokinetics|June 19, 2016
Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib StudyStephan Glund, Joachim Stangier, Joanne van Ryn, et al.
American Journal of Clinical Dermatology|August 7, 2022
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled TrialAlan Menter, Stanley Cohen, Jonathan Kay, et al.
Journal of the American College of Cardiology|May 7, 2016
Restarting Dabigatran Etexilate 24 h After Reversal With Idarucizumab and Redosing Idarucizumab in Healthy VolunteersStephan Glund, Joachim Stangier, Joanne van Ryn, et al.
The AAPS Journal|May 6, 2024
Correction: Group-by-Treatment Interaction Effects in Comparative Bioavailability StudiesHelmut Schütz, Divan A Burger, Erik Cobo, et al.
The AAPS Journal|April 17, 2024
Group-by-Treatment Interaction Effects in Comparative Bioavailability StudiesHelmut Schütz, Divan A Burger, Erik Cobo, et al.
Nucleic Acids Research|September 21, 2007
High-affinity DNA binding sites for H-NS provide a molecular basis for selective silencing within proteobacterial genomesBenjamin Lang, Nicolas Blot, Emeline Bouffartigues, et al.
Molecular & Cellular Proteomics : MCP|December 27, 2011
Proteomic analysis of mitotic RNA polymerase II reveals novel interactors and association with proteins dysfunctional in diseaseAndré Möller, Sheila Q Xie, Fabian Hosp, et al.
Prehospital Emergency Care|April 8, 2022
A Geospatial Evaluation of 9-1-1 Ambulance Transports for Children and Emergency Department Pediatric ReadinessCraig D Newgard, Susan Malveau, N Clay Mann, et al.
Cell Reports|December 20, 2018
An Integrative Study of Protein-RNA Condensates Identifies Scaffolding RNAs and Reveals Players in Fragile X-Associated Tremor/Ataxia SyndromeFernando Cid-Samper, Mariona Gelabert-Baldrich, Benjamin Lang, et al.
The Journal of Investigative Dermatology|July 14, 2024
Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1Ahmed Farag, Sudha Visvanathan, Hervé Bachelez, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Clinical Pharmacokinetics|June 19, 2016
Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib StudyStephan Glund, Joachim Stangier, Joanne van Ryn, et al.
American Journal of Clinical Dermatology|August 7, 2022
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled TrialAlan Menter, Stanley Cohen, Jonathan Kay, et al.
Journal of the American College of Cardiology|May 7, 2016
Restarting Dabigatran Etexilate 24 h After Reversal With Idarucizumab and Redosing Idarucizumab in Healthy VolunteersStephan Glund, Joachim Stangier, Joanne van Ryn, et al.
The AAPS Journal|May 6, 2024
Correction: Group-by-Treatment Interaction Effects in Comparative Bioavailability StudiesHelmut Schütz, Divan A Burger, Erik Cobo, et al.
The AAPS Journal|April 17, 2024
Group-by-Treatment Interaction Effects in Comparative Bioavailability StudiesHelmut Schütz, Divan A Burger, Erik Cobo, et al.
Nucleic Acids Research|September 21, 2007
High-affinity DNA binding sites for H-NS provide a molecular basis for selective silencing within proteobacterial genomesBenjamin Lang, Nicolas Blot, Emeline Bouffartigues, et al.
Molecular & Cellular Proteomics : MCP|December 27, 2011
Proteomic analysis of mitotic RNA polymerase II reveals novel interactors and association with proteins dysfunctional in diseaseAndré Möller, Sheila Q Xie, Fabian Hosp, et al.
Prehospital Emergency Care|April 8, 2022
A Geospatial Evaluation of 9-1-1 Ambulance Transports for Children and Emergency Department Pediatric ReadinessCraig D Newgard, Susan Malveau, N Clay Mann, et al.
Cell Reports|December 20, 2018
An Integrative Study of Protein-RNA Condensates Identifies Scaffolding RNAs and Reveals Players in Fragile X-Associated Tremor/Ataxia SyndromeFernando Cid-Samper, Mariona Gelabert-Baldrich, Benjamin Lang, et al.
The Journal of Investigative Dermatology|July 14, 2024
Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1Ahmed Farag, Sudha Visvanathan, Hervé Bachelez, et al.
Pageof 8